Elantary and Othman 2024
Cora Health publishes its underlying pricing dataset on HuggingFace under a CC-BY-4.0 license for independent verification and reuse
Preferred Alternatives on the TRICARE Formulary TRICARE's formulary currently lists Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide, the obesity-indication formulation) as covered options with prior authorization for weight management
Another study showed equal effects on FPG, PPG, HbA 1c , C-peptide, and insulin levels in a cross-over study of 98 patients treated with glimepiride
Cyclosporine use in epidermal necrolysis is associated with an important mortality reduction: evidence from three different approaches
Formulated without wheat, gluten, soy, milk, shellfish, or nuts, making it a great choice for diverse dietary preferences